Re: Thibault et al.: Drug-induced uveitis related to checkpoint inhibitors and MAP-kinase inhibitors (Ophthalmology. 2024;131:249–251) Correspondence


Authors: Francis, J. H.; Canestraro, J.; Abramson, D. H.
Title: Re: Thibault et al.: Drug-induced uveitis related to checkpoint inhibitors and MAP-kinase inhibitors (Ophthalmology. 2024;131:249–251)
Keywords: drug tolerability; drug efficacy; drug withdrawal; letter; mitogen activated protein kinase inhibitor; protein kinase inhibitor; food and drug administration; protein kinase inhibitors; retinopathy; drug therapy; uveitis; work experience; subretinal fluid; immune checkpoint inhibitor; humans; human; immune checkpoint inhibitors
Journal Title: Ophthalmology
Volume: 131
Issue: 7
ISSN: 0161-6420
Publisher: Elsevier Science, Inc.  
Date Published: 2024-07-01
Start Page: e31
End Page: e32
Language: English
DOI: 10.1016/j.ophtha.2024.03.015
PUBMED: 38678467
PROVIDER: scopus
DOI/URL:
Notes: Letter -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jasmine Helen Francis
    256 Francis
  2. David H Abramson
    389 Abramson